Go back to MDS Pharma Services home page


          
 
Spacer
Safety Pharmacology


Company

According to the principles set forth in the ICH S7a and ICH S7b guidance, it is essential to evaluate the safety pharmacology profile of a new compound. Safety Pharmacology studies are usually divided into two categories:
  • Core studies – Studies designed to evaluate the essential processes of respiration and CNS
  • Supplemental studies – Studies designed to provide further information on the pharmacology of the test material. These studies allow us to look at areas such as the GI tract.

Our experienced scientists will design a detailed protocol customized to suit your specific needs.

For more information on study design, pricing, contract and turnaround contact your MDS Pharma Services representative.

 
Skip Navigation Links.

Contact MDS Pharma Services Toxicology and Safety Pharmacology:

Phone:
33-4-74-01-63-63
Email:
lyon.lab@mdsinc.com

or fill out an Online Request
Spacer

© 2009 MDS Pharma Services     |     Corporate Governance     |     Legal     |     Privacy     |     Site Map